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Breast biopsy clips are frequently present in the field of view (FOV) of magnetic 
resonance images (MRI) of the breast. These clips, typically ranging in size from 2 – 4 
mm in length, are inserted by a radiologist during a primary tumor biopsy, and may 
remain in the FOV for all subsequent scan sessions. As most breast biopsy clips are 
constituted of non-ferromagnetic metal, they are broadly labeled as “MRI Safe” and can 
be imaged with little or no discomfort from the patient. However, the susceptibility 
difference will induce significant artifacts in MRI. Currently, radiologists are trained to 
ignore these distortions in traditional MRI scans. However, with the increased use of 
quantitative imaging methods such as dynamic contrast enhanced MRI (DCE-MRI) to 
inform and evaluate treatment, the susceptibility effects from non-ferromagnetic metal in 
the FOV cannot be ignored. These distortions become increasingly important during 
therapy as common treatments seek to shrink the size of large masses prior to surgical 
removal or further imaging studies. Therefore, it is necessary to characterize the effects 
of these clips on DCE-MRI in a controlled manner.  To proceed in this fashion, we 
designed a novel phantom setup consisting of a set of traditional T1 phantoms to 
characterize the effects of susceptibility artifacts on DCE-MRI pharmacokinetic 
 vii 
parameters. In this study, we investigate the effectiveness of multiple material types to 
form the phantoms, evaluate the deviations in pharmacokinetic parameters from clip 
artifacts, and compare this to quantitative measurements of susceptibility artifacts from 
breast biopsy clips. We ultimately determine that the current phantom construct method 
is not able to effectively capture the error introduced by the breast biopsy clips and 
discuss several paths to improving and stabilizing this design.  
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List of Tables .......................................................................................................................x 
List of Figures .................................................................................................................... xi 
Chapter 1: Introduction ........................................................................................................1 
Introduction to MRI Theory .......................................................................................1 
Introduction to DCE-MRI ...........................................................................................3 
Susceptibility Differences in MRI ..............................................................................4 
Breast Biopsy Clips ....................................................................................................6 
Current Phantom Design for Susceptibility Differences in Breast Biopsy Clips .......6 
Chapter 2: Phantom Construction ........................................................................................9 
Material Selection .......................................................................................................9 
Phantom Generation .................................................................................................10 
Multi-Layer Procedure ..............................................................................................11 
T10 Approximation ....................................................................................................12 
Temperature Dependence of T10 ...............................................................................14 
Location Determination with Computed Tomography .............................................17 
Chapter 3: Pharmacokinetic Simulation ............................................................................21 
Quantitative DCE-MRI Modeling ............................................................................21 
Ideal Curve Modeling ...............................................................................................22 
Sample Selection.......................................................................................................23 
 ix 
Phantom Creation and T1 Mapping ...........................................................................23 
Parameter Fitting.......................................................................................................24 
Error Calculation.......................................................................................................26 
Simulation of Effects of Breast Biopsy Clips on DCE-MRI ....................................26 
Chapter 4: MRI Experiments .............................................................................................30 
Susceptibility Mapping .............................................................................................30 
Parts-per-million Quantification ...............................................................................31 
Raw Data Extraction and Reconstruction .................................................................33 
SNR Comparison Experiment ..................................................................................35 
Susceptibility Artifacts and Pharmacokinetic Modeling ..........................................37 
PPM Off-Resonance Calculation ..............................................................................39 





List of Tables 
Table 1: Modeled T1 values in the phantom set and the corresponding contrast agent 
dosing values. Both phantom sets were modeled to the same T1 values in 
column 3 using the amount of contrast agent specified in column 4. 
Indexed timepoint refers to the index of phantom within the modeled 
curve timecourse. ..........................................................................................24 
  
 xi 
List of Figures 
Figure 1: Cross section of a gelatin phantom containing a breast biopsy clip. Slice 
selected shows the distortion in full prominence. Within this 125 mm 
diameter phantom, a titanium breast biopsy clip of 4 mm generates an 
artifact of approximately 10 mm at 3T. ..........................................................5 
Figure 2: MRI cross section image of a full gelatin phantom set containing clip and 
not containing clips. Left column is one entire phantom set slip into a 
single slice of the top and the bottom rows of the containers. The same 
was performed for the no clip phantoms in the second column. ..................11 
Figure 3: Concentration vs 1/T1 curve. Line of best fit is displayed on the graph along 
with the resulting equation. 95% confidence intervals are displayed at 
each data point. .............................................................................................13 
Figure 4: Temperature Effect on T1 of Gelatin: the T1 of each of the phantoms over a 
range of reasonable temperatures for the phantoms to achieve. Both the 
P2 and the P1 phantoms were produced in-duplicate. As temperature 
rises, we see an increase in the T1 of all phantoms, with a decrease in 
change as the concentration of CA increases within the phantom. Error 
bars indicate 95% confidence intervals.........................................................15 
Figure 5: Temperature Effect on r1 of Gelatin, the r1 of each of the phantoms over a 
range of reasonable temperatures for the phantoms to achieve. Both the 
P1 and the P1 phantoms were produced in-duplicate. A consistent 
decrease is experienced by r1 as the temperature is raised in the phantom 
overall. 95% percent confidence intervals are included at each point. .........16 
 xii 
Figure 6: The left hand image refers to the co-registered images of the CT and MRI 
binary maps. The pink image portion is the CT image, while the green 
pixels are the MRI image. Areas of successful overlap are colored in 
white. The right figure is a binary CT with circle of best fit displayed to 
allows us to remove extra material outside the phantoms prior to 
registration. ...................................................................................................19 
Figure 7: Registered Binary CT and the MRI scans with the best view of the clip 
distortions. We can see the two pieces of copper placed on the phantom 
prior the CT scan and the clip centered in the binary CT image, as well 
as the distortion of the clip on the left. ..........................................................20 
Figure 8: Simulated DCE-MRI curve using population AIF and known Ktrans¸and ve. 
The stared points represent the points selected to represent the curve. 
The red circles indicate uniform time sampling over the entire AIF time 
frame. Ktrans is set to 0.2 min-1, while ve is set to 0.1. ...................................22 
Figure 9: (A) Gathered calculated concentration curve from B1-field adjusted T1 maps 
of gelatin phantoms. (B) Modeled uptake curves from the mean and 
median Ktrans and ve gathered from the fit data in (A). From this image, 
we visually see a faithful reproduction of the simulated uptake curve and 
little deviation between mean and median of the fit parameters. .................25 
Figure 10: T1 maps of the simulated clip case and its corresponding no clip case. A 
single cross sectional slice that best displays the knockout region present 
in the phantoms and its corresponding slice for the no clip case. .................28 
Figure 12: Percent error between the two parameters as the spherical ROI is increased 
in radius. Error bars represent the 95% confidence interval of the 
average parameter error at each point. ..........................................................30 
 xiii 
Figure 13: Central coronal slice of SNR phantom taken by a single channel donut 
coil. Visual inspection indicates relative similar SNR patterns across 
both images. ..................................................................................................36 
Figure 14: Central coronal slice of SNR phantom (slice 15) scanned in a 32-channel 
RF head coil. Visual inspection indicates relative similar SNR patterns 
across both images. Siemens Console reconstruction displays higher 
SNR overall. ..................................................................................................36 
Figure 15: 12 mm radius ROI outline displayed around a breast biopsy clip artifact. 
Red line indicates the edge of the spherical ROI on a single image cross 
section. ROI extends into other slices as well to from a sphere in 3D. 
Container is 70 mm in diameter. ...................................................................38 
Figure 16: Cross-sectional image of the PPM maps obtained from a breast biopsy 
clip. There is a distortion at the center of the phantom that corresponds 
with the clips location within the phantom. ..................................................39 
Figure 17: (A) 1D visualization of PPM around the clip through the center of the 
distortion along the longest axis of the distortion. (B) 1D path through 
the artifact on the relevant slice. Note that there is a space between the 
phase barrier that the 1D projection runs through so it is not displayed.......40 
Figure 18: Average PPM measurements for clip over the radius of the volume of the 
ROI. Each point was generated using concentric spherical ROIs and 
averaged over the size of the each ROI. .......................................................41 
 xiv 
Figure 19: (A) Gathered calculated concentration curve from B1-field adjusted T1 
maps of gelatin phantoms for the no clip case of phantom set #1. (B) 
Modeled uptake curves from the mean and median Ktrans and ve gathered 
from the fit data in (A). We see deviation in the median and mean fit 
curves that is not seen in the previous empty phantom case.........................42 
Figure 20: (A) Gathered calculated concentration curve from B1-field adjusted T1 
maps of gelatin phantoms for the clip case of phantom set #1. (B) 
Modeled uptake curves from the mean and median Ktrans and ve gathered 
from the fit data in (A). .................................................................................43 
Figure 21: Single coronal cross section slice of spherical (A) Ktrans and (B) ve percent 
error maps for phantom set #2 at maximum ROI. Both maps are centered 
on the clip location and represent a 12 mm radius spherical tumor..............44 
Figure 22: Mean percent error curves as a function of spherical ROI radius for 
phantom set #2. Error bars represent the 95% confidence interval of the 
measurements. ...............................................................................................44 
Figure 23: (A) Gathered calculated concentration curve from B1-field adjusted T1 
maps of gelatin phantoms for the no clip case of phantom set #2. (B) 
Modeled uptake curves from the mean and median Ktrans and ve gathered 
from the fit data in (A). Some deviation between the mean and the 
median curves is observed. ...........................................................................46 
Figure 24: A) Gathered calculated concentration curve from B1-field adjusted T1 maps 
of gelatin phantoms for the clip case in phantom set #2. (B) Modeled 
uptake curves from the mean and median Ktrans and ve gathered from the 
fit data in (A). Similar to the no clip case for phantom set #2, we see 
slight deviations between the mean and median fit curves. ..........................47 
 xv 
Figure 25: Single coronal cross section slice of maximum ROI size of spherical (A) 
Ktrans and (B) ve error maps. Both maps are centered on the clip location 
and represent a 12 mm spherical tumor. .......................................................48 
Figure 26: Mean percent error curves as a function of spherical ROI radius for 




Chapter 1: Introduction 
Magnetic resonance imaging (MRI) is a clinically important imaging technique that 
utilizes the magnetic resonance of the protons of hydrogen atoms in water to generate a 
signal that can be measured with an appropriately placed radiofrequency coil [1], [2]. The 
inherent difference in water content in anatomical/tissue structures is used to gather high 
resolutions images without the use of ionizing radiation. Breast cancer specifically has seen 
widespread use of the modality from the detection of lesions with screening scans, to 
evaluating the response of treatment [3]. MRI is distorted by metallic objects within the 
scans field of view [4]. This becomes important when objects, such as breast biopsy clips 
placed in the center of biopsied breast lesions, are obscuring the anatomical structure under 
investigation. While there has been extensive research into the quantification and 
suppression of these artifacts in intensity image, very little research has been devoted to 
understanding how these artifacts affect more quantitative methods such as dynamic 
contrast enhanced MRI (DCE-MRI) [5], [6]. In this project, we seek to develop and 
evaluate a new method for quantifying the effects of breast biopsy clips on DCE-MRI. We 
begin with the underlying concepts and clinical uses of MRI and DCE-MRI. 
 
INTRODUCTION TO MRI THEORY 
MRI scanners generate a high strength magnetic field known as the B0 field. 
Varying between 1.5T – 7T in most clinical settings, this field is used to yield the net 
magnetization vector (generated from the hydrogen nucleus of water molecules denoted as 
M) parallel to the B0 field [1]. This alignment (classified as the z direction) is not sufficient 
to generate measurable signal to reconstruct an image. Therefore, we apply a 
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radiofrequency (RF) pulse perpendicular to the B0 field, which exerts a torque on M to push 
it into the axis perpendicular to the B0 field (i.e. the x-y plane) where it precesses at the 
Larmor frequency [2]. This “tipping” of M induces a signal in the receiver coils and 
decreases as M relaxes to return to the lower energy alignment parallel to the B0 field after 
removal of the RF pulse. This relaxation can be classified into two major forms: 
longitudinal relaxation (characterized by the time constant T1) and transverse relaxation 
(characterized by the time constant T2) [7], [8]. 
T1 and T2 relaxation have units of time (typically seconds or milliseconds), and both 
denote the amount of time for M to return to 37% of its initial value in their respective 
directions [9]. T1 refers to the return of M to alignment with the B0 field and is dependent 
on temperature as well as the structure of the specific material being examined [10]. T2 
refers to the loss of consistent phase of M in xy plane and shows the phase coherence of 
the xy-plane returning to the Boltzman distribution [10]. Both values present themselves 
as a distinct change in the signal detected by the receiver coils over time. 
While MRI scans can be controlled with many acquisition parameters [8], we will 
focus on those most important for the present study: TR, TE, and flip angle (α). TR, or the 
repetition time, is the period between individual RF excitation of material [8]. TE refers to 
the echo time, or the period between RF excitations of the material, and the echo gathered 
by the receiver coils [8]. By varying these two parameters, MR images with vastly different 
signal and contrast profiles can be generated. For example, short TR and TE images are 
said to be T1-weighted, while a long TR and a long TE result in a T2-weighted image [9]. In 
other words, T1 and T2 are the primary determinants for the intensity of the image, instead 
of pure proton density. Finally, the flip angle is the angle from parallel to B0 that M 
experiences after the application of the RF pulse [11].  
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INTRODUCTION TO DCE-MRI  
DCE-MRI requires the use of contrast agents (CA) to alter tissue’s relaxivity within 
the region that the agent has perfused [12]. CA are aqueous compounds that are injected 
intravenously to the subject during an MRI scan [13]. While there are wide-range of CAs 
available, this study focuses on the use of the Gadolinium-based compounds [14]. The 
inclusion of these compounds adds a time-varying component between each of the 
subsequent scans performed on the patient. As the CA travels throughout the bloodstream, 
the CA perfuses into the extravascular space and changes the inherent T1 of the surrounding 
tissue [15]. This changes the signal intensity, as well as the relaxivity, as a function of the 
CA concentration present in the voxel [12]. Observing this change with multiple MRI scans 
over the course of a single session allows for characterization of the delivery, accumulation, 
and elimination of CA from tissues of interest. This time varying image data, or image time 
course, allows us to characterize physiological qualities of the tissue in that area using 
quantitative and semi-quantitative models. For breast cancer specifically, both types of 
models have been successful at the detection and classification of breast lesions as benign 
or malignant [16], [17]. In the case of semi-quantitative models, many methods focus on 
the evaluation of the signal-enhancement curve, or the change in the degree of image 
enhancement within a voxel of the image time course [16]. The enhancement curves are 
matched to one of several types, indicating whether the tumor is statistically likely to be 
malignant or benign [16]. In the case of the quantitative models, the time course is fit to a 
mathematical model and several pharmacokinetic parameters are obtained that describe 
various bulk phenomena within the tissue[18]. These parameters can be used as biomarkers 
for specific qualities related to (for example) level of vascularity, presence of necrosis, or 
normal vs cancerous tissue [19]. In this study, we focus on a single quantitative model 
known as the Kety-Tofts model. 
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SUSCEPTIBILITY DIFFERENCES IN MRI 
Within the realm of metallic materials used for medical application, there exist 
specific metals that are MRI-compatible. These metals are typically paramagnetic and will 
not move or experience significant forces while within the B0 field of the MRI scanner [6] 
[20]. While this classification is useful for classifying what materials can safely enter the 
vicinity of the MRI magnet, there are several sub-categories within this label that need to 
be considered when it comes to MRI image quality and artifacts. These “MRI-safe” 
materials are typically divided depending on the susceptibility difference between the 
material and water. Susceptibility is defined as the degree of magnetization of a material 
when a magnetic field is applied. The first type of MRI compatible materials typically do 
not experience meaningful forces within the MRI field, but can result in large image 
distortions in sufficient quantities if within/near the image field of view (FOV). Titanium, 
the material many breast biopsy clips are composed of, is classified within this group [5]. 
  The rapid changes in susceptibility gradients across the FOV result in warped 
magnetic fields that change the resonate frequency of the hydrogen nuclei in the area. These 
off-resonance effects cause image blackout in some regions along the readout direction, by 
preventing the excitation of the relevant protons with the RF pulse, and/or shifting of the 
intensity associated with a voxel to a different voxel [6]. This results in the varied shapes 
of the distortions depending on the readout direction, but the most characteristic shape is 
the chevron. Figure 1 presents an example of one of these artifacts generated by a breast 
biopsy clip.  
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Figure 1: Cross section of a gelatin phantom containing a breast biopsy clip. Slice 
selected shows the distortion in full prominence. Within this 125 mm 
diameter phantom, a titanium breast biopsy clip of 4 mm generates an 
artifact of approximately 10 mm at 3T. 
When susceptibility differences between water and MRI-safe materials are 
sufficiently large, the difference results in a change in the total magnetic field strength at a 
certain point in the image. This is seen in the first group of MRI safe materials. This shift 
is dependent on both strength of the B0 field as well as the strength of the localizing 
gradients used to encode spatial information [21]. However, utilizing smaller B0 field 
results in decrease image quality overall in MRI, (due to a reduction in available signal) 
minimizing the viability of this solution [22]. Therefore, as B0 field strength of MRI 




BREAST BIOPSY CLIPS 
During the diagnosis and biopsy of non-palpable breast abnormalities, it has 
become standard practice to insert a tissue marker at the center of the site of biopsy [23]. 
These clips are typically made of a range of materials, but the non-ferromagnetic metal 
types range from 3-5 mm in length. These markers are MR-safe and are designed to mark 
the center of the lesion throughout treatment and have been shown to remain stationary 
years post insertion [24]. Therefore, it is highly likely to see such clips present in the 
primary FOV in subsequent imaging studies. When present, these clips will form 
susceptibility artifacts and will occlude parts of the FOV.  
 
CURRENT PHANTOM DESIGN FOR SUSCEPTIBILITY DIFFERENCES IN BREAST BIOPSY 
CLIPS 
Comparability of results between different scanners, scan sites, and field strengths 
is incredibly important for both the clinical and the research realm. Typically, repeatability 
across imaging sites is confirmed using MRI phantoms with known T1, T2, and signal-to-
noise ratios [25]. As the uses of DCE-MRI continue to expand, the development of 
standardization tools for the comparison of these techniques between institutions has also 
expanded. Typical phantom used for DCE-MRI are perfusion-based [26]. These devices 
can generate highly reproducible flow characteristic but are relative complex devices that 
typically require three major parts: a source for contrast agent, a standardized diffusion 
restriction mechanism, and a material that is capable of being perfused with a liquid 
contrast agent [27]. However, to the best of our knowledge, there have been not been any 
attempts to utilize the perfusion phantoms for analysis of susceptibility artifacts, as of the 
writing of this thesis. In fact, many of the currently existing perfusion-based phantoms are 
ill-fitted for the stereotaxic localization of a clip within the phantom and are focused on 
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quantifying changes in perfusion over time. For the purposes of this study, we instead focus 
on the development of a unique phantom system designed to better facilitate the analysis 
of susceptibility artifacts.   
Previous attempts to quantify the susceptibility artifacts for breast biopsy clips 
within standard MRI have utilized single material phantoms with a known T1 comparable 
to the tissue in question [4]. These phantoms do not control for position of the clip within 
the material and use the industry standard insertion method to prevent deviation from 
clinical presentation. These phantoms benefit from stability and continuity of the 
surrounding material, allowing for the quantification of artifacts without interference from 
the complexities of tissue inhomogeneity.  
With the limited level of development around quantification of the artifacts induced 
by biopsy clips, the next step is to adopt a perfusion phantom type that maintains the 
material homogeneity of single material phantoms. Without a good understanding of the 
effects of these clips on a range of lesion sizes, clinicians and researchers will be required 
to omit large amounts of data near the clip in order to prevent its affects from being felt in 
clinical decisions or research analysis. This problem is especially poignant in breast 
imaging, where the inclusion of breast biopsy clips in the FOV is extremely common [23]. 
In some cases, the full view of the lesion may be occluded and/or data may be 
untrustworthy [4]. Only by gaining a better method of isolating the effects of these clips 
will we be able to understand to what extent DCE-MRI data can be trusted within the 
regions of these clips. 
The most direct way to characterize the effects of breast biopsy clips on 
pharmacokinetic analysis would be to acquire DCE-MRI of the same structure with and 
without the presence of a clip within a patient. However, this is practically prohibitive in 
patients. To address this problem, we constructed a set of phantoms with T1 values similar 
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to those present within clinical human breast tumors to mimic DCE-MRI curves. It is the 
goal of this project to develop a this novel multi-phantom design to successfully isolate the 
effects of the clips on DCE-MRI. We will evaluate the phantom design, material selection, 
and finally present the results of the effects of the clips on DCE-MRI analysis with mean 
percent parameter error around the clips with an increasing spherical ROI. Finally, we 
compare these results to off-resonance analysis, a method of quantifying susceptibility 

















Chapter 2: Phantom Construction 
MATERIAL SELECTION 
When deciding among established phantom materials to utilize, two major 
requirements were discussed. First, the ability of the phantoms to hold the biopsy clips in 
a fixed location during the scan is a necessity. As the primary goal of this project is to 
isolate the effects of the clips using a standardized material structure, we need to effectively 
mimic the uptake curve of a pharmacokinetic parameter and isolate the distortions.  To 
achieve this, the stability of the location of the clips during the scan is of the utmost 
importance. Second, the material must be (at least) optically translucent to visually locate 
the clips within the material and confirm that the phantom was correctly constructed prior 
to scanning. This minimizes the occurrence of unnecessary scans when a clip was 
incorrectly positioned, or an air-bubble has formed in the material during production. 
 Previous efforts have used water/fat solutions to generate uniform phantoms with 
reproducible fat fractions [28]. Unfortunately, upon production of these phantoms, we 
found stabilizing the clips in a uniform, 3D position difficult. These agar-based phantoms 
have also been designed to mimic the T1 of tissue in MRI scanners. The materials required 
are non-toxic, clear, and gelation can be pH dependent depending on the materials used 
[29]. However, we found that the materials tended to form air bubbles very easily when 
the phantoms were produced. Air-tissue boundaries are additional sources of susceptibility 
differences [30] that must be avoided to prevent disrupting our results in this study. 
 The final material evaluated in this study was gelatin. This material has seen limited 
use in the literature but has been used to mimic breast tissue in previous analysis of 
susceptibility differences in breast biopsy clips [4]. Gelatin proved itself to be easy to 
produce, translucent, and produced few air bubbles upon the production of phantoms. 
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Furthermore, the material survived multiple pours within the same container. This quality 
proved essential in consistently isolating the clip location. In this study, we utilized Gelatin 
derived from bovine skin (Sigma-Aldrich, G9382-1KG) 
 
PHANTOM GENERATION 
To generate a DCE-MRI time course in a patient, contrast agent is injected 
venously, and perfuses throughout the body during the scan until it removed by the kidneys 
[12]. Multiple images are taken over the course of the contrast agent’s path, and the level 
of contrast agent within each voxel is determined. The change in the amount of contrast 
agent within each voxel per unit time forms the DCE-MRI uptake curve [12]. To simulate 
the DCE-MRI uptake curve, we posit that a compromise between the time resolved data of 
perfusion phantoms, and the uniform material phantoms can capture the effects of 
susceptibility artifacts in DCE-MRI. Therefore, we propose a novel phantom style that 
utilizes two sets of identical gelatin phantoms doped with varying levels of CA. Each 
phantom within each set is infused with a specific concentration of CA that represents a 
specific time point in a simulated DCE-MRI uptake curve. Each member of one of these 
sets contains a single biopsy clip from an identical batch of ten clips that is placed in the 
center of the phantom with its rotation controlled and its longest axis oriented with the B0 
field to minimize distortions [31]. The second set of phantoms has no clips embedded and 
acts as a reference set of varying-contrast concentration phantoms against those with clips. 
Figure 2 provides a full example of this phantom set. By calculating the error in DCE-MRI 
pharmacokinetic parameters between the phantoms spatially, we hope to quantify the 
divergence of these parameters from expected values when the clip is present.  
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Figure 2: MRI cross section image of a full gelatin phantom set containing clip and not 
containing clips. Left column is one entire phantom set slip into a single 
slice of the top and the bottom rows of the containers. The same was 
performed for the no clip phantoms in the second column.   
MULTI-LAYER PROCEDURE 
To embed the clips within the phantoms in a controlled 3D position, clinical 
insertion methods could not be used. Typical breast biopsy clip insertion is achieved via a 
small, single-use, prepackaged needle [32]. These methods do not control for the 3D 
rotation of the clip, and do not allow for consistent placing of the clips within the phantoms. 
Furthermore, air bubbles were a problem around the clip after insertion by standard 
techniques. Therefore, we adopted a 3-layer method that minimized heterogeneity within 
the phantom, while also allowing for consistent placing of the clips within the material. 
First, a batch of phantom material is produced, doped with CA, and 250mL of the material 
is poured to fill phantom containers for the standard, empty phantoms. Half of a second set 
of phantom containers (125mL) are then filled with gelatin and allowed to set. The 
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remaining material is used to embed the clip within a small 60 mm dish in a stable 
orientation. A second batch of material is produced with the same concentration of contrast 
agent. The clip, embedded in gelatin from the first batch, is placed over the bottom layer 
of material, and a second identical layer is poured above. This results in the stable 
embedding of the clip within the center of the material, without the variability of standard 
insertion methods. Furthermore, this procedure can be repeated multiple times with the 
same clip set, allowing for the evaluation of multiple phantom sets without added expense 
of new clips or new single use insertion mechanisms.  
 
T10 APPROXIMATION 
To effectively model the DCE-MRI uptake curve and PK parameters, we need to 
charecterize the baseline T1 of gelatin prior to the additions of contrast agent. From this 
experiment, we hope to gain three things. First, confirm that the T1 of gelatin can be 
consistently set to a value determined via calculations. Second, we hope to gain the baseline 
T1 of phantoms prior to CA additions. Finally, we plan to confirm that the slope of the 
effects of contrast agent will results in the expected T1 values. 
In this simple experiment, we poured five phantoms. 200mL of water was heated 
at 220oC for 15 min on a hot plate. At the 15 min mark, 0.056 g/mL of gelatin was added. 
Each phantom was doped individually with [0, 0.6, 1.2, 1.8, 2.4] mM of Gadabutrol 
(Gadavist, Bayer) representing the concentrations in each of the phantoms and allowed to 
set overnight. All phantoms were scanned at room temperature (ie. 20o C) These phantoms 
were scanned using a Siemens Skyra 3T using a 32 channel head-coil. Ten scans were 
performed at different flip angles ranging from 2 to 20 degrees with voxels of 1.4 × 1.4 × 
5 mm3, over a 192 by 144 by 20 acquisition matrix. B1-field maps were acquired to adjust 
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for RF field inhomogeneities. The resulting T1 maps were averaged from 900 samples 
within the center of each phantom. Figure 3, represents the concentration to relaxation rate 
curve of the gelatin phantoms gathered from these phantoms.  
 
 
Figure 3: Concentration vs 1/T1 curve. Line of best fit is displayed on the graph along 
with the resulting equation. 95% confidence intervals are displayed at each 
data point.  
By obtaining an average of 900 voxels within the center of the no CA phantom, we 
obtain the T10 of the phantoms is 1,700 msec. By repeating this with all phantom and 
performing a linear fit, we obtain an r1 of 4.5 sec
-1mM-1. The established value of 
Gadabutrol at 3T in plasma is 4.54 sec-1*mM-1 [33]. From these results we make the 
following statements. First, gelatin is a reasonable material for mimicking the T1 changing 
effects of clinically used concentration agents. Second, relatively low variance across the 
phantoms indicate that this material should be effective to variation from clip artifacts. 
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TEMPERATURE DEPENDENCE OF T10 
 During the course of the initial experiments on modeling the pharmacokinetic 
paramters, we noticed a variation in the T1 of the phantoms that seemed consistent with 
changes in T1 with respect to temperature. While this was not originally identified as a 
possible issue due to short scan times, a simple experiment was performed to detect 
changes in T1 in gelatin over the expected range of temperatures.  
To confirm that the T1 of gelatin was stable across the expected temperature range 
of the scan, we evaluated the same phantoms set at the range of temperatures from storage 
to room temperature. It has been established from post-mortem MRI scans, as well as tissue 
samples, that the T1 of tissue does vary with temperature [34], [35], therefore it is important 
to understand the level of deviation expected by gelatin.  From this experiment, we hope 
to inform phantom storage and scanning procedure to avoid variation of T1 within the 
phantoms themselves. This is even more important in the context of this project, where 
phantoms correctly mimicking their modeled T1’s is an underlying axiom. 
Five gelatin phantoms were prepared using the standard procedure stated 
previously. The Gadovist (Gadabutrol) concentration levels were set at [0.3354 and 
0.1013] mM. Each of these concentrations was labeled as P1 and P2, respectively and 
created in duplicate. The final phantom, labeled T10 contained no CA and was used to 
evaluate the intrinsic variation of T1 of the material. All phantoms were scanned at 5 
different temperatures [0 3.6 7 12 19.7]o Celsius using the center of a different, identical 
phantom to measure the internal temperature of the phantoms at scan time. These 
temperatures represented the temperatures of the phantoms removed from storage at 0 
hours, 1 hour, 2 hours, 4 hours, and 8 hours, respectively. All phantoms were scanned 
within the same FOV using a Siemens Skyra 3T scanner with a 32-channel head coil. T1 
was fitted using the MFA method, with ten scans ranging from 2 to 20 in flip angle with 
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voxels of 1.4 × 1.4 × 5 mm3 over a 192 by 144 by 20 acquisition matrix. B1-field scans 
were obtained to adjust for RF field variance and T1 fitting error correction [36]. From these 
scans we obtained Figure 4 and 5, which represent the variation of T1 within the phantoms 
due to temperature. Relaxivity over the range of temperature was also evaluated. The 
relaxivity, or r1 of the material is the rate of the change of the relaxation rate, or the inverse 
of T1 per unit of contrast agent [33] 
 
 
Figure 4: Temperature Effect on T1 of Gelatin: the T1 of each of the phantoms over a 
range of reasonable temperatures for the phantoms to achieve. Both the P2 
and the P1 phantoms were produced in-duplicate. As temperature rises, we 
see an increase in the T1 of all phantoms, with a decrease in change as the 
concentration of CA increases within the phantom. Error bars indicate 95% 
confidence intervals.  
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Figure 5: Temperature Effect on r1 of Gelatin, the r1 of each of the phantoms over a range 
of reasonable temperatures for the phantoms to achieve. Both the P1 and the 
P1 phantoms were produced in-duplicate. A consistent decrease is 
experienced by r1 as the temperature is raised in the phantom overall. 95% 
percent confidence intervals are included at each point. 
T1 or the longitudinal relaxation constant, increases with the temperature of the 
material. This is consistent with previous studies of human tissue and cadavers [34]. 
Furthermore, we see a decrease in the change in T1 as the level of concentration agent in 
increases. To confirm a stable r1 between different temperatures, we calculated the 
effective r1 of each of the phantoms using the T1 of the phantom and the T10 phantom. From 
this calculation, we obtain Figure 3. At 19.6 oC, we receive an effective r1 of 4.634 sec
-
1mM-1, consistent with our earlier experiment. A different baseline T1 was observed due to 
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the variation between gelatin batches. This experiment highlights the need to control 
material temperature during scans. If this cannot be done, a baseline T1 phantom should be 
present to detect any shift in baseline T1. 
LOCATION DETERMINATION WITH COMPUTED TOMOGRAPHY 
 Susceptibility artifacts tend to fully occlude the location of the breast biopsy clip 
within the signal dropout region [37] as the artifacts can be far larger than the clip itself. 
Furthermore, their appearance, size, and location can shit depending on the relationship 
between the data acquisition direction and the B0 field strength [6]. This indicates that the 
center of the artifact may not represent the center of the breast biopsy clip phantoms. This 
indicates the need for a localization method that does not rely on MRI for determining the 
location of the clips within the gelatin. Therefore, we utilized x-ray computed tomography 
(CT) to determine the location of the breast biopsy clips within the gelatin phantoms.  
Phantom Construction 
While the CT images allows for localization of the clips without the effects of 
artifacts obscuring the clips from view, it does introduce a new issue: how to spatially 
register the two imaging modalities. As the phantoms were moved from scanner to scanner, 
it was likely that phantoms would rotate and deviate from the expected orientation. To 
account for rotation of the phantoms between MRI scans and the CT scans, a small 4 × 4 
Lego brick was inserted and filled with gelatin at the bottom of the phantoms. This allowed 
for the minimization of any artifacts present from air within the brick, while also providing 
a point of reference for the registration of the images. An example of a CT to and an MRI 
image registration is provided below in Figure 6.  
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Localization Experiment Procedure  
First, each of the phantoms was constructed with the clip, and the lego brick 
inserted. This is the same procedure discussed previously with the inclusions of the filled 
Lego brick at the bottom of the container during the initial pour. Then, two small pieces of 
copper wire were attached to the side of the phantom at the same height as the clip. The 
phantoms were then scanned with an Inveon PET/CT. Each phantom was affixed to the 
table to assure the phantom was stable and in a reproducible orientation to the scanner. 
Scans were acquired with a 479 × 479 × 479 acquisition matrix size over a 95 x 95 x 95 
mm FOV. The phantoms were then scanned as a single unit on a Siemens Skyra 3T MRI 
scanner with a gradient spin echo sequence with a voxels size of 1.4 × 1.4 × 5 mm3, over a 
192 by 144 by 40 acquisition matrix, a TE and TR of 2.3600 msec, and 7.9 msec, and flip 
angle of 20o. We convert both the MRI image and the CT image to binary images by setting 
all voxels below an intensity threshold to zero and all voxels above the threshold to one. 
From these binary maps, we search for the slices that contain the greatest number of voxels 
that represent the clip or Lego brick. The best slice is classified as the slice that contains 
the greatest number of voxels referring to the clip or the Lego brick within the FOV. CT 
and the MRI scan have a circle that best encompasses the phantom container. This circle 
is used to generate an ROI within the binary maps to remove extraneous material as shown 
in Figure 6 below. A best fit rectangle is also applied to indicate the location of the Lego 
brick. These binary images are then registered in 2D and the resulting transform is applied 
to the clip slice to obtain the location of the clip in 2D. We assume that the structure 
designed to hold the phantoms in place during the MRI scan minimizes all movement and 
holds the phantoms vertical. This assumption allows for the application of the same 2D 
transform across multiple slices. We assume that z axis shifting in the MRI scan is minimal 
due to the much larger voxel size. Figure 6 show a registered Lego slice, as well as the 
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best-fit circle utilized to remove extraneous data from the rigging in the CT scan. Figure 
7 shows the registration of the clip slice using the transform displayed in Figure 6.  
 
Figure 6: The left hand image refers to the co-registered images of the CT and MRI 
binary maps. The pink image portion is the CT image, while the green pixels 
are the MRI image. Areas of successful overlap are colored in white. The 
right figure is a binary CT with circle of best fit displayed to allows us to 
remove extra material outside the phantoms prior to registration. 
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Figure 7: Registered Binary CT and the MRI scans with the best view of the clip 
distortions. We can see the two pieces of copper placed on the phantom 
prior the CT scan and the clip centered in the binary CT image, as well as 
the distortion of the clip on the left.   
Results and Discussion 
From the image registration method presented above, we obtained clip locations 
that differed from the center of the distortions by 1-2 MRI voxels, or 1.4-2.8 mm. The 
variation between clip and distortion location did not exceed 3 mm for all cases tested.  
While the decision to inform the location of the clip within the distortion is valid, 
and confirmed via the difference between the CT clip location and the center of MRI, these 
results call into question the need for CT registration in the case of breast biopsy clips as a 
whole. These adjustments were still performed to mark the clip location more accurately 
within the phantoms, but it is highly unlikely that registration like this would be useful in 
a clinical setting. The added exposure of the patient to ionizing radiation is not justifiable 
for the goal of localizing a clip. However, this does indicate that marking the distortions of 
breast biopsy clips using the center of the distortion is relatively accurate at 3T.  
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Chapter 3: Pharmacokinetic Simulation 
QUANTITATIVE DCE-MRI MODELING 
Of the many DCE-MRI models that exist, the Kety-Tofts model is perhaps the most 
commonly used. This model is built upon the framework of vascular and extracellular 
compartments that each contain a time dependent concentration of contrast agent [12].  
 
The equation for how contrast agents with a known relaxivity, r1 shortens T1 of the 
blood from its intrinsic T10 is: 
Where C is the concentration of the contrast agent in the blood, and T1 is the final measured 
T1 of the material.  
From the Kety Tofts model, we fit for two major parameters that can provide insight 
into the tissue properties of a breast tumor: Ktrans and ve. K
trans is typically interpreted as the 
rate of transfer from the blood plasma to the extracellular space [38], while ve is interpreted 
as the volume fraction of the extravascular space [39]. In this model, Ktrans  and ve can be 
influenced by a wide range of physical properties in the tissue depending on the vessel 
permeability as well as the flow characteristics of the surrounding vessels [40]. Cp(t) 
represents the level of contrast agent in the blood, and Ct(t) represents the level of contrast 
Kety-Tofts 
𝐶𝑡(𝑡) = 𝐾













+ +𝑟1𝐶        (3.2) 
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agent in the tissue space. Cp(t) is typically referred to as the arterial input function (AIF), 
and can be measured, or assumed for clinical purposes [18]. 
IDEAL CURVE MODELING 
For the purposes of this study, we selected a predetermined set of Ktrans and ve 
values, and obtained the Ct(t) expected for the given AIF. This results in the curve seen 
below in Figure 8. In this study, the AIF was determined from a population of patients 
being scanned as part of an ongoing imaging study [41], using the method outlined in [42].  
 
 
Figure 8: Simulated DCE-MRI curve using population AIF and known Ktrans¸and ve. The 
stared points represent the points selected to represent the curve. The red 
circles indicate uniform time sampling over the entire AIF time frame. Ktrans 
is set to 0.2 min-1, while ve is set to 0.1. 
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SAMPLE SELECTION 
From the curve seen in Figure 8, we selected ten points to be represented with 
phantoms. The goal with this sampling was to specify five points from the period before 
the peak of the uptake cure, and five points from the decay of the uptake curve. Figure 9 
below lists these points, their timestamp index in the simulation curve, and the 
concentration of contrast agent modeled by those points.  
PHANTOM CREATION AND T1 MAPPING  
Each of the phantoms was generated using the procedure specified above and using 
the concentrations specified in Figure 9. Both the clip containing phantom sets and the no 
clip containing phantom sets are identical in the dosing and their modeled T1.  
 
Phantom Number Indexed Timepoint Desired T1 (ms) Contrast Agent Concentration (mM) 
1 1 1292 0.0199 
2 8 1094 0.0448 
3 10 619 0.170 
4 13 392 0.338 
5 15 375 0.358 
6 17 400 0.329 
7 22 533 0.216 
8 28 691 0.140 
9 40 818 0.100 
10 55 839 0.0945 
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Table 1: Modeled T1 values in the phantom set and the corresponding contrast agent 
dosing values. Both phantom sets were modeled to the same T1 values in 
column 3 using the amount of contrast agent specified in column 4. Indexed 
timepoint refers to the index of phantom within the modeled curve 
timecourse. 
In the Spoiled Gradient Echo Signal Equation displayed in equation (3.3), α 
represents the flip angle of the scan, and So refers to the scaled spin density of the image. 
TE, TR, T1, and T2 are all parameters discussed thoroughly in the introduction to this thesis. 
To re-obtain the concentration curve from the simulated curve, we must first 
calculate the T1 values of the material. This is done via a multi-flap angle method (MFA) 
which utilizes multiple MRI images at a range of flip angles to fit for the T1 of a material 
[43]. The T1 maps are fit by least-squared method to the spoiled gradient echo signal 
intensity equation [9], shown below, and we obtain the T1 values of the phantoms in a 
voxel-wise method. We include a B1 field map during the T1 weighting sequences to 
minimize the variability in the flip angle maps acquired [36].  All full phantom sets were 
scanned within the same FOV using a Siemens Skyra 3T scanner. T1 was fitted using the 
MFA method, with ten scans ranging from 2 to 20 in flip angle with voxels of 1.4 × 1.4 × 
5 mm3, over a 192 by 144 by 40 acquisition matrix,.  
PARAMETER FITTING 
After fitting T1 values to each of the ten phantoms, a spherical ROI is generated 
around each of the clips and the voxels are classified by their distance and angle from the 
clips. Each corresponding voxel is then placed in its corresponding time point and used to 




exp( −TE/T2)           (3.3) 
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fit a Ktrans and ve in the Kety-Tofts model for each voxel. This results in a set of curves as 
well as parameter maps that can be used to spatially evaluate the parameter values. In 
Figure 10, we present an example phantom set that results in the collected curves seen in 
Figure 9a. These concentration curves are then fit to Kety-Tofts, and we obtain a mean 
and median Ktrans and ve value that are modeled and presented here in Figure 9b.  
 
 
Figure 9: (A) Gathered calculated concentration curve from B1-field adjusted T1 maps of 
gelatin phantoms. (B) Modeled uptake curves from the mean and median 
Ktrans and ve gathered from the fit data in (A). From this image, we visually 
see a faithful reproduction of the simulated uptake curve and little deviation 
between mean and median of the fit parameters. 
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From this phantom set, we receive an average Ktrans of 0.1881 min-1 (+/- 0.01), and 
observed a 5.95% error between the modeled and gathered Ktrans. We received an average 
ve of 0.1411 (+/- 0.0085) , and observed a 41.1% percent error against the modeled ve. The 
modeled parameters were Ktrans and ve of 0.2 min
-1  and 0.1 respectively. This result is not 
ideal and shows issues modeling the desired Ktrans and ve effectively using this setup. This 
experiment did not account for temperature changes in the phantoms and its effect on T1. 
In Figure 10, we show the gathered concentration curve. These are generated by spatially 
resolving all of the calculated concentrations from each of the phantoms and aligning the 
points with their temporal position in the uptake curve. This is then fit to Kety-Tofts. The 
mean and media curves are then display in Figure 9 to indicate that the median and mean 
of the phantom are essentially identical in this phantom set. 
 
ERROR CALCULATION 
Error is defined in this experiment as the percent difference between the 
pharmacokinetic parameters obtained from the no-clip phantom set and the parameters 
obtained from the clip phantoms sets. This error is performed on a voxel by voxel basis 
and compared over an increasing spherical ROI around the center of the clip. The resulting 
curves are intended to act as a analogue for the level of certainty physicians can expect a 
that distance from the breast biopsy clip.  
 
SIMULATION OF EFFECTS OF BREAST BIOPSY CLIPS ON DCE-MRI 
The image distortion generated by breast biopsy clips is typically seen in the form 
of intensity knockout in the relative region of the clip’s location [6]. While there are other 
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affects that radiate out from the clip [4] that effect the image in less obvious ways, this is 
the primary method by which the image is distorted upon visual inspection. To gain an 
understanding of what to expect from the error maps, we simulated how the removal of a 
single region within the center of a single phantom set would affect average parameter error 
withing the phantoms.  
Procedure 
All phantoms were scanned within the same FOV using a Siemens Skyra 3T 
scanner with a 32-channel head coil. T1 was fitted using the MFA method, with ten scans 
ranging from 2 to 20 in flip angle with voxels of 1.4 × 1.4 × 5 mm3 over a 192 by 144 by 
40 acquisition matrix with TE and TR of 2.3600 msec, and 7.9 msec. B1-field maps were 
obtained for T1 fitting and adjustment. After the gathering of the MFA scans for the 
phantoms, we selected a voxel in the central region of each phantom and knocked out the 
intensity information around this pixel in a 2 mm radius for all scans. These scans are then 
used to fit for T1 via the MFA method and the resulting T1 maps are presented below in 
Figure 10. Utilizing the multi-phantom setup that we have developed, we took the no clip 
phantoms, and artificially created signal dropout regions at central locations within each 
phantom, at each flip angle. We then performed T1 fitting, calculated the parameter error 
between this data, and the results of the unedited scans. This data was then evaluated 
spatially by averaging the parameter error inside spherical ROIs centered around the 
simulated clips of various sizes. Shown in Figure 10 are the edited T1 maps and the original 
T1 maps.  
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Figure 10: T1 maps of the simulated clip case and its corresponding no clip case. A single 
cross sectional slice that best displays the knockout region present in the 
phantoms and its corresponding slice for the no clip case.  
Results/Discussion 
As presented by the Ktrans and ve error maps in Figure 11, we see a region of 100% 
error at 2 mm ROI size. This directly overlaps with the knockout region that encompasses 
most of the error when comparing the two phantoms. By averaging the error over an 
increasingly large spherical area to mimic the presentation of a large overall lesion size, 
we see that there is an exponential decrease in the average error as the radius of the 
spherical ROI increases as seen in Figure 12. This decrease is mirrored with the 95% 
confidence intervals, except for the first point which encompasses only the simulated signal 
dropout region and has low variation. This is as expected as the number of voxels 
encompassed by the ROI increases exponentially with the increased radius. From this 
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simulation we obtain three major understandings. First, the simulated signal dropout region 
should result in a centralizing source of error within the phantoms. Second, we seen an 
idealized version of the error maps if the two phantom sets are identical copies of one 
another, as this project attempts to create. Third, increasing ROI size,  an analog for 
increased lesion sizem should lead to decreased overall error within in these phantoms. 
This is the gold standard we will try to be replicating with subsequent phantom sets. This 
simulation is inadequate in two major areas. First, the idealized knockout regions displayed 
here are not the reality within the phantoms. The knockout regions typically present signal 
that does change with the flip angle. This obscures the location of the simulated signal 
dropout region in the T1 maps. Second, the focus of this project is obtaining an 
understanding of the effects from breast biopsy clips beyond simple blackout regions that 
could be a major source of error in phantoms. This simulation does not try to mimic these 
effects.  
Figure 11: Ktrans and ve error maps for the simulated clip case against the no clip case. The 
area of 100% error is the region blacked out in the simulation. Error between the two 




Figure 12: Percent error between the two parameters as the spherical ROI is increased in 
radius. Error bars represent the 95% confidence interval of the average 
parameter error at each point. 
Chapter 4: MRI Experiments 
SUSCEPTIBILITY MAPPING 
Recent work has measured the size of susceptibility artifacts by directly comparing 
the diameter of intensity knockout regions across different field strengths [44]. While these 
methods are effective for the quantification of the level of artifact distortion in traditional 
MRI, they may not represent the full extent of the artifacts which could affect DCE-MRI 




Some previous work with breast biopsy clip artifact quantification has focused 
around the analysis of different clips, using parts-per-million (PPM) as the primary method 
of comparison [4]. PPM quantifies the field inhomogeneity within the phantom by utilizing 
shifts in the surrounding material’s RF excitation frequency. This shift is calculated from 
the phase buildup between two scans that vary with TE and is expected to increase in areas 
of high susceptibility differences [45]. However, this approach produces the problem of 
separating the inherent magnet inhomogeneities from those presented by the clips. To do 
this, we approach the calculation of PPM via the difference of accumulated phase between 
two scans of two phantoms [4]. In this setup, one set of scans contains the clip, while the 
second contains a uniform, blank phantom. By comparing the phase buildup between the 
blank and the clip phantoms, we can obtain only the PPM associated with the clip’s effects. 
The formula for PPM can be derived starting from the phase measured in a single 
RF coil shown in equation (4.1) seen in [46]. In this equation, ∆𝐵 is the field 
inhomogeneity, 𝑟 is the spatial location in the image, 𝛾 is the gyromagnetic ratio, and TE 
is the TE of the gathered image. 𝜑𝑗(𝑟, 𝑇𝐸) represents the total phase generated by an image.  
 
𝜑𝑗(𝑟, 𝑇𝐸) = 2𝜋𝛾𝑇𝐸∆𝐵(𝑟)              (4.1) 
 As phase is periodic, there is typically a process of unwrapping that is applied which 
can be seen in equation (4.2), where the unwrapped phase is represented by 𝜑𝑗, and where 
𝜑𝐿 is either 0 or - 𝜋 in most applications.  
Φ =  𝜑𝑗  𝑚𝑜𝑑2𝜋 +  𝜑𝐿                        (4.2) 
Despite the typical need for phase unwrapping in phase images, proper selection of a range 
of TEs for the expected frequency range of off-resonance can minimize the need for phase 
unwrapping, resulting in 𝜑𝑗 and Φ being equivalent, but only for the period between m and 
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n, our selected phases. Therefore, we convert 𝜑𝑗 to the phase between the two images at 
different TEs, and we arrive at equation (4.3). 
 
Φ𝑚−𝑛(𝑟, 𝑇𝐸) = 2𝜋𝛾∆𝑇𝐸∆𝐵(𝑟)               (4.3) 
 
Now, when we want to calculate the phase difference between two unwrapped phases at 
two different TEs, defined here as m and n, we apply equation (4.4), which can be transform 
into equation (4.5) by being put in terms of a complex image, where arctan2 refers to a 
version of arctan that ranges from - 𝜋 to 𝜋, and I* is the complex conjugate of the complex 
image.  
  Φ𝑚−𝑛 =  ∠ exp(𝑖(𝛷𝑚 −  𝛷𝑛))                 (4.4) 
 Φ𝑚−𝑛 =  𝑎𝑟𝑐𝑡𝑎𝑛2(𝐼𝑚 ∗ 𝐼𝑛
∗)                      (4.5) 
 
If we substitute equation (4.5) to equation (4.3), move all constants to the left-hand side, 








(𝑟)  (4.6) 
 
To remove the off-resonance due to inhomogeneities present from the magnet itself, we 
expand equation (6) to include two more images that represent the phantoms without off-
resonance generating biopsy clips, but subject to the same scan parameters. We then scale 
this argument by their intensities. This results in the final form of the equation for PPM, 
equation (4.7) [4]. Images with the subscript of clip indicate the presence of an 
inhomogeneity source, while control indicate the control phantom without an 
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inhomogeneity source (the clip) present. Furthermore, m and n indicate the TEs at which 







∗  ∗ 𝐼𝑛,𝑐𝑜𝑛𝑡𝑟𝑜𝑙
|𝐼𝑚,𝑐𝑜𝑛𝑡𝑟𝑜𝑙| ∗ |𝐼𝑛,𝑐𝑙𝑖𝑝|  
) = 𝑃𝑃𝑀 (4.7)  
 
To fulfill the requirements of this equation, we also needed to select a TE difference 
that could effectively capture the phase buildup without the need for phase unwrapping. 
This difference can be calculated via the range of frequencies expected [47] or the 
following equation (8). Previous studies of breast biopsy clips at 1.5T have utilized a 2 
msec difference in TE, with breast biopsy clips of similar material and design. Therefore 
in this study, we assumed similar frequency shifts, and selected 1ms as the  𝛥𝑇𝐸 to account 
for the change in field strength to 3T. This accounts for a range of +/- 500 Hz.  
 
𝛥𝑇𝐸 × 𝛥f < 1             (4.8) 
 
Prior to PPM calculation, the images are registered, and the formula defined in 
equation (4.7) is applied in a voxel by voxel method. In this study, we used a TE difference 
of 1 msec with each acquisition’s values set to 3.31 msec and 4.31 msec. This was the 
shortest TE we could utilize while preventing partial k-space acquisition from being 
required by the Siemens scanner. 
RAW DATA EXTRACTION AND RECONSTRUCTION 
While MR images are acquired as complex signal with imperfections that result in 
phase, the images extracted from vendors are written to DICOM-format files are typically 
magnitude based with the phase excluded. Therefore, the raw MRI data needs to be 
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extracted from the scanner and reconstructed manually to utilize the PPM formula. 
Extraction of the raw data requires vendor-specific tools. 
Raw data is extracted from the MRI scanner in the form of free induction decays or 
FIDs that are not useful for human visualization and require reconstruction [48]. 
Conversion of these FIDs to typical MR images require processing that is referred to under 
the umbrella term of MRI reconstruction [8]. The automated reconstruction is typically 
extremely complex and proprietary and may include steps that are designed to suppress or 
minimize the distortions that we are attempting to measure in this project [49]. However, 
the general reconstruction process is well established and the subject of current and long 
running research. From this, we have extracted several steps that are to achieve images of 
a quality sufficient for this project. Sufficient is defined as comparable SNR patterns 
between both reconstruction images as well as achieving SNR levels within 20% of the 
Siemens console reconstruction.  
Post data extraction, our reconstruction process can be divided into three major 
steps. First, the k-space data is apodized using a cosine bell function to minimize high 
frequency information that is likely just noise. Second, the discrete Fourier transform was 
used to convert the raw data from frequency space to image space. Third, the multiple coil 
channel signals were combined via their respective image weights, and sum-of-squares on 
a per slice basis to form the image [8]. To confirm that this methodology was accurate at 
portraying the fully reconstructed images, the experiment below was constructed. This is 
designed to display a basic example of the reconstruction process and its comparison 
against a Siemens vendor image. 
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SNR COMPARISON EXPERIMENT 
To generate a phantom with consistent signal while also closely mimicking the 
expected phantom size for the PPM measurements, we created a blank, 500 mL gelatin 
phantom and dosed it with 1 mM of Gadolinium. This phantom was then scanned with 
single channel donut coil on a Siemens Skyra 3T scanner. The scan parameters are as 
follows, 320 by 320 by 30 acquisition matrix with 0.5 × 0.5 × 2 mm3 voxel sizes. The TE 
and TR were 4 msec, and 300 msec respectively. The raw k-space of the scan was extracted 
and reconstructed using the process discussed above. The noise level in the magnitude 
images was calculated by using a 50 x 50 voxel region in each slice external to the phantom 
that was then used to calculate SNR for the whole image [50]. The reconstructed images 
are displayed in Figure 13 and 14 for both the developed reconstruction method as well as 
the Siemens proprietary reconstruction, 
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Figure 13: Central coronal slice of SNR phantom taken by a single channel donut coil. 
Visual inspection indicates relative similar SNR patterns across both 
images.  
Figure 14: Central coronal slice of SNR phantom (slice 15) scanned in a 32-channel RF 
head coil. Visual inspection indicates relative similar SNR patterns across 
both images. Siemens Console reconstruction displays higher SNR overall. 
Results and Discussion 
The averaging of 2500 point within the two phantoms results in an average SNR of 
16.23 (+/- 1.32), and 15.14 (+/- 0.90) for the raw data and the Siemens reconstruction, 
respectively. This is consistent with our needs for a consistent reconstruction method that 
results in comparable SNR images. The process was repeated for the phantoms scanned in 
the 32 channel head coils. They achieved an average SNR of 114.81 (+/- 22.12) and 148.51 
(+/- 3.21) for the raw reconstruction and the vendor reconstruction. This deviation upon 
the introduction of multiple coils was likely the result of weighting individual channels 
upon reconstruction. While this is somewhat managed using the header provided coil 
scaling factor, there are far more complex adjustments made in the real-time reconstruction 
processes. The raw reconstruction deviated more significantly in the 32-channel head coil 
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case, and the overall SNR values were relatively consistent. This showed that the 
reconstruction algorithm was relatively effective at approximating the SNR seen in 
standard DICOM images in this case. 
SUSCEPTIBILITY ARTIFACTS AND PHARMACOKINETIC MODELING  
The final and most important portion of this projects is comparing the degree of 
off-resonance detected around the clips in question with the error detected by the clip 
phantoms in the DCE-MRI phantoms. All portions of the project are incorporated in this 
analysis.  
Procedure 
Gelatin phantom sets were formed via the methods discussed above to the T1 values 
specified in Figure 9, modeling the phantoms to mimic known Ktrans and ve values of 0.2 
min-1 and 0.1 respectively. One phantom set was embedded with the SecurMark Titanium 
top-hat shaped breast biopsy clip (Hologic, Inc), while the other was composed of a single 
pour of gelatin material (see Figure 2). These phantoms were scanned using X-ray 
computed tomography (CT) to determine the location of the clips within the gelatin, since 
CT is not subject to metal artifacts. MFA with B1 field correction was used to generate T1 
maps of the phantoms [36] that were then aligned and fit to the Kety-Tofts DCE-MRI 
model using the least-square fitting method. A second, 500 mL gelatin phantom was 
created, and a clip was embedded into the material using the 3-layer method discussed 
earlier. This phantom was then scanned using a 0.2 × 0.2 × 2 mm3 voxel size with 640 x 
320 x 40 matrix in a 32-channel head coil. TR was 300 msec, and TE was 3.31 msec /4.31 
msec for the two sets of scans. PPM was calculated from the extracted raw data using the 
formula derived above. Both phantom sets were scanned on a Siemens Skyra 3T scanner. 
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Both set of phantoms were then scanned using TE, TR of 2.3600 msec, and 7.9 msec, 
respectively, with 192 by 144 by 40 acquisition matrix with 1.4 × 1.4 × 5 mm3 voxel sizes 
using a standard chest coil. Each scan set was performed with a range of 10 flip angles 
from 2 to 20 degrees with B1 correction maps included.  
Error Quantification 
The two curve sets were then compared on a voxel-by-voxel basis. Percent error 
between the two curves was computed between the two data sets and averaged over an 
increasing ROI size to mimic an increasing tumor volume. By comparing the percent error 
between the phantom sets and an increasing ROI size, we hoped to understand the relative 
error experienced for a wide range of lesion sizes. In Figure 15, we display the maximum 
ROI size utilized in this study, 12 mm, around a clip artifact in a single phantom. From this 
image, we can see that there is sufficient space between the ROI edge and the edges of the 
phantoms to minimize air-material effects on analysis. 
 
 
Figure 15: 12 mm radius ROI outline displayed around a breast biopsy clip artifact. Red 
line indicates the edge of the spherical ROI on a single image cross section. 
ROI extends into other slices as well to from a sphere in 3D. Container is 70 
mm in diameter. 
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PPM OFF-RESONANCE CALCULATION 
After the SecurMark clip was inserted into another gelatin phantom that was dosed 
with gadolinium for increased SNR. PPM analysis of the off-resonance was performed 
over the entire phantom. Figure 16 displays a single cross section of the phantom that best 
represents the full distortion from the clip. By taking a 1D central line through the of the 
distortion along its longest axis, as seen in Figure 17, we can observe the longest distances 
from the center of the clip, where PPM returns to the background phantom levels of ~0.2 
ppm.   
 
Figure 16: Cross-sectional image of the PPM maps obtained from a breast biopsy clip. 
There is a distortion at the center of the phantom that corresponds with the 
clips location within the phantom. 
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Figure 17: (A) 1D visualization of PPM around the clip through the center of the 
distortion along the longest axis of the distortion. (B) 1D path through the 
artifact on the relevant slice. Note that there is a space between the phase 
barrier that the 1D projection runs through so it is not displayed. 
As we can see from Figure 17 and Figure 18, there is minimal phase wrapping due 
to the efficient selection of the TE difference, and a rather significant artifact present in the 




Figure 18: Average PPM measurements for clip over the radius of the volume of the ROI. 
Each point was generated using concentric spherical ROIs and averaged 
over the size of the each ROI. 
As shown in Figure 18, PPM was averaged over the entire ROI with the center of 
the PPM distortion labeled as the center of the ROI. This second curve displayed the 
average PPM with increasing ROI size around the clip. Note the similarities between the 
overall curve shape and the simulation of the Ktrans  and ve error in Figure 12. As expected, 
the PPM values return to phantom baseline further from the clip when compared to the 
error presented with the intensity knockout region.  
PHARMACOKINETIC PARAMETER ERROR QUANTIFICATION 
Full Clip Phantom Set #1 Results and Discussion 
After analysis, CT registration, and pharmacokinetic parameter fitting, the first 
phantom set constructed curves are shown in Figure 19 and Figure 20. The mean Ktrans 
was 0.1633 min-1 (+/- 0.0144) and the mean ve was 0.1264 (+/- 0.0208) for the no clip case. 
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For the clip case, Ktrans and ve results were 0.1130 min
-1 (+/- 0.174) and 0.1061 min-1 (+/- 
0.0093), respectively. Both error maps showed consistent error across the defined volume 
as shown by Figure 21 and 22. Neither the error curve present in Figure 22, nor the error 
maps seen in Figure 21 seem to display any behavior due to the clip insertion in the 
phantom. The inherent differences between the two phantoms seems to either account for 
all error present or overshadow and deviations driven by the clip artifacts.  
   
 
Figure 19: (A) Gathered calculated concentration curve from B1-field adjusted T1 maps of 
gelatin phantoms for the no clip case of phantom set #1. (B) Modeled uptake 
curves from the mean and median Ktrans and ve gathered from the fit data in 
(A). We see deviation in the median and mean fit curves that is not seen in 




Figure 20: (A) Gathered calculated concentration curve from B1-field adjusted T1 maps of 
gelatin phantoms for the clip case of phantom set #1. (B) Modeled uptake 




Figure 21: Single coronal cross section slice of spherical (A) Ktrans and (B) ve percent 
error maps for phantom set #2 at maximum ROI. Both maps are centered on 
the clip location and represent a 12 mm radius spherical tumor.  
 
Figure 22: Mean percent error curves as a function of spherical ROI radius for phantom 
set #2. Error bars represent the 95% confidence interval of the 
measurements.  
Due to the large amount of parameter error present in the phantoms over the 
increasing sizes of the ROI as seen by Figure 22, we cannot determine if the error is a 
result of the clip artifact distortion. It is possible that increasing the number of averages in 
the MFA scan will increase the accuracy of the T1 measurements, and the parameter fitting. 
However, a far more likely issue is the effect of temperature on scanning. Therefore, 
subsequent phantom experiments will more carefully control for temperature variation 
during scan time. When observing the error maps presented in Figure 21¸we see a 
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relatively consistent error level across the view of the ROI, consistent with the results of 
Figure 22. These error maps represent a single slice of the full cylindrical ROI with the 
position of the clip denoting the center. The lack of presentation of the clip in the error map 
in a manner similar to the simulations in Figure 12, indicate that the inherent error from 
the phantoms is overshadowing the error present from the clips overall. An interesting 
artifact in Figure 19 is the deviation from the mean and median coherence that we saw in 
the early phantom sets as seen in Figure 10. Further, the extreme variance in phantom 10 
when compared to the other phantoms in the set might indicate an error in production that 
was not replicated in the other phantoms. 
Full Clip Phantom set #2 Results and Discussion 
Due to the lackluster results presented by phantom set #1, a second set was 
constructed that was designed to minimize the effects of temperature differentials during 
the scan, as well as maximize the accuracy of the T1 measurements. The phantoms were 
scanned using five averages for each flip angle to lower the presence of noise in the images. 
A phantom without any contrast agent was incorporated into the scan to confirm if there 
were any deviations from the expected baseline T1 as well as to confirm if temperature 
differentials within the phantoms were a factor in the previous error. The phantoms were 
only removed from cold storage for the period of the scan and total exposure to room 
temperatures was minimized to 30 minutes.  CT scans were not able to be gathered for 
phantom set #2 due to COVID19 and shut down of all research scanning facilities. 
However as mentioned, deviation of the center of the distortion from the center of the clip 
is minimal. 
The average gathered Ktrans for the no clip case was determined to be 0.1569 min-1  
(+/- 0.0124), and the ve was calculated to be 0.1353 (+/- 0.0101). The K
trans and ve for the 
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clip case were determined to be 0.1369 min-1 (+/- 0.0509) and 0.1416(+/- 0.0126), 
respectively. Percent error calculation per voxel shows consistent error for both the Ktrans 
the ve between the clip and the no clip case across the phantom. Error as a function of radius 
stays consistent until 12 mm where it spikes from an increase in error towards the edge of 
the ROI.  
As seen in Figure 23 and 24, the gathered curves present in phantom set #2 are 
much more consistent with the curves originally modeled in Figure 8 and 10. The clip case 
results in higher overall variation within the phantom, but we see error patterns that are not 
consistent with our simulations in Figure 26. 
 
 
Figure 23: (A) Gathered calculated concentration curve from B1-field adjusted T1 maps of 
gelatin phantoms for the no clip case of phantom set #2. (B) Modeled uptake 
curves from the mean and median Ktrans and ve gathered from the fit data in 
(A). Some deviation between the mean and the median curves is observed. 
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Figure 24: A) Gathered calculated concentration curve from B1-field adjusted T1 maps of 
gelatin phantoms for the clip case in phantom set #2. (B) Modeled uptake 
curves from the mean and median Ktrans and ve gathered from the fit data in 
(A). Similar to the no clip case for phantom set #2, we see slight deviations 
between the mean and median fit curves. 
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Figure 25: Single coronal cross section slice of maximum ROI size of spherical (A) Ktrans 
and (B) ve error maps. Both maps are centered on the clip location and 
represent a 12 mm spherical tumor.  
 
Figure 26: Mean percent error curves as a function of spherical ROI radius for phantom 
set #2. Error bars represent the 95% confidence interval of the 
measurements.  
From the increase in the number of averages, and better temperature control at scan 
time, we see little to no improvement in the performance of the phantoms to capture the 
error presented by the biopsy clip’s distortion. There is an overall decrease in the average 
error when compared to phantom set #1 initially, but there exists little pattern to the error 
that could be considered comparable to the simulations see in Figure 12. The increase of 
error at a larger ROI is particularly puzzling. This would make one believe that the air-
boundary at the edge of the phantom was beginning to become an issue. However , the 
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phantom size is significantly larger than the largest ROI size and should prevent the air-
phantom boundary from providing interference as seen in Figure 15. This would indicate 
a larger issue with the phantoms that is not being addressed. None of the ROIs intersect 
with the registration lego-brick location, and it is filled with gelatin to prevent air 
boundaries from becoming a factor. In general, we cannot say that the clip artifact is 
contributing to the error seen between the phantoms due to the overwhelming internal error 
in the phantoms. Furthermore as we can see from Figure 25, the increase in error as the 
ROI increases in size is consistent with spatial error maps taken at the slice nearest to the 
clip. A positive sign is the decrease in variance as seen in the acquired scans for the no clip 
case. This is much closer to the ideal simulated case when compared to phantom set #1. 
This indicates that higher number of averages is needed and will likely be instrumental in 
decreasing phantom error in later sets. 
Phantom Set Discussion  
 Despite multiple attempts over the course of multiple phantom sets, we were unable 
to determine the effects of breast biopsy clips on the Kety-Toft pharmacokinetic 
parameters. The high levels of parameter error experienced by even the blank phantoms 
seems to obscure understanding if the clip artifacts contribute to any deviation we see from 
expected values. When comparing these results against the PPM measurements around the 
clips, we are unable to determine the relationships between the clip off-resonance and 
parameter error. This is unfortunate, as the driving force behind this project was to 
determine if such a relationship could exist. The high levels of error presented by the non-
clip phantoms is interesting, as early experiments seemed to indicate that gelatin was an 
effective material for consistently modeling T1 in phantoms. The deviation from this 
behavior is an important consideration and warrants an examination of different materials 
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that could be used instead of gelatin for this experiment. The high levels of error, yet low 
levels of variation in the parameters in the no clip case seems to indicate that the gelatin is 
relatively stable, yet the fit parameters are still far from reasonably accurate. There is also 
the possibility that an inefficient set of points were selected to represent the curve. Better 
point selection could be performed via principle component analysis over a variety of 
curves to determine the ideal points for best mimicking the curves in phantoms. Future 
work would be needed to determine the ideal set of points to represent and differentiate 
various the DCE-MRI uptake curves and then re-attempt this study. The inclusion of more 
points/phantoms into the study is possible, but this current attempt seems to reach the 
maximum number of phantoms allowable by available coils, while still providing enough 





 With the ever-increasing use of quantitative imaging techniques in diagnosis and 
treatment evaluation in breast cancer, it is important to evaluate the effects that breast 
biopsy clip artifacts can have on varying tumor sizes and stages. Breast biopsy clips, 
typically present in the FOV of tumors that were not surgically resected, would be expected 
to play a role in occluding tumor, as well as causing distorting off-resonance effects beyond 
the primary signal black-out region. This could lead to problems in data accuracy in 
quantitative imaging techniques like DCE-MRI. In this project, we have attempted to create 
a 3-pronged approach to quantify the various effects of breast biopsy clips and begin to 
correlate, understand, and track them. First, we generated quantitative parameter maps with 
gelatin phantoms doped with CA. Second, we registered the clips using CT scans to provide 
accurate clip localization. Upon application of this method however, it is determined that 
the benefits of the use of the CT localization method are minimal at best. Third, we used 
PPM measurements to determine the level and extent of off-resonance effects within the 
phantoms to gain an understanding of the expected size of any effects on the parameters. 
This was all united using parameter error as a judgement of the ultimate effects that breast 
biopsy clips were expected to display in a variety of simulated tumor sizes. Unfortunately, 
inherent error within the phantoms prevented gaining a full understanding of these effects 
and warrants a careful reevaluation to determine if the methods of fitting T1 inherently 
minimize the effects of the biopsy clips. One area of interest is the TE selected for T1 fitting 
measurement is significantly shorter than those present in clinical scanners. The reduction 
of phase buildup in the T1 map may explain a portion of the reason that these artifacts were 
not detected effectively. A second area of possible evaluation prior to this project’s re-
attempt would be the phantom construction method. While the method presented here does 
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minimize the number of pours, and stabilizes the clip orientation more than standard 
insertion methods, the multiple layers do present a confounding variable. However, the 
large amount of error displayed by the blank phantoms seems to indicate that the 3-layer 
method is not a major source of error. Despite this, comparison of multiple layers of the 
clip phantoms did not reveal large amounts of variation in T1. This result minimizes the 
possibility of this effect being a major component. The most important area to be examined 
is the between phantom deviation displayed by the control phantoms in this project. 
Controlling for temperature, as well as increasing the number of averages did seem to 
minimize the amount of variation in gathered curves, as seen by phantom set #2, but does 
not solve the problem of between phantom issues. As these phantoms are generated from 
the same batch of gelatin, with the same concentration of CA, it is likely something far 
more inherent to the phantom construction method that has not been addressed. These 
issues prevent us from being able to draw a consistent correlation between the parameter 
error and the PPM displayed around the clip. However, the methods discussed here, and 
the approach, are reasonable in design. This leads us to expect that future attempts of this 
project will provide additional insight into errors in quantitative MRI imaging due to the 
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